Risk factor for acute kidney injury in patients with chronic kidney disease receiving valve surgery with cardiopulmonary bypass

医学 急性肾损伤 肾功能 体外循环 透析 肌酐 肾脏疾病 单变量分析 风险因素 入射(几何) 心脏外科 内科学 外科 多元分析 光学 物理
作者
Hsun-Yi Fu,Nai‐Kuan Chou,Yih‐Sharng Chen,Hsi‐Yu Yu
出处
期刊:Asian Journal of Surgery [Elsevier BV]
卷期号:44 (1): 229-234 被引量:14
标识
DOI:10.1016/j.asjsur.2020.05.024
摘要

Acute kidney injury (AKI) after cardiopulmonary bypass (CPB) in patients with pre-existing impaired renal function carries deleterious outcomes but is not frequently evaluated. The optimal CPB strategy for preventing AKI in this vulnerable patient group is still controversial. A total of 156 patients with preoperative estimated glomerular filtration rate (e-GFR) <30 ml/min but not on chronic dialysis receiving valve operation under CPB were included in the present study. Postoperative AKI was defined as KDIGO (Kidney Disease Improving Global Outcomes) stage 3. Hospital mortality and two-year renal function evolution were compared between patients with postoperative AKI and those without AKI. Risk factors for the development of postoperative AKI were also studied. The incidence of postoperative KDIGO-3 was high (44.2%). Hospital mortality was higher in the AKI group (30.4%) than in the non-AKI group (8.0%). Among the hospital survivors, renal function deterioration to permanent dialysis at two years was also more common in AKI group (14.5%) than in non-AKI group (4.6%). Univariate logistic regression for postoperative AKI revealed male gender, increased age, height, weight, BSA, and BMI, high preoperative serum creatinine, prolonged CPB duration, and decreased CPB target temperature as risk factors. However, multivariate analysis revealed only high preoperative serum creatinine and decreased CPB target temperature as significant risk factors for postoperative AKI. To prevent postoperative AKI in CKD patients, low CPB target temperature is avoided, especially for those with high preoperative serum creatinine levels.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
SciGPT应助明天见采纳,获得10
刚刚
今后应助争渡采纳,获得10
1秒前
2秒前
陶醉黑猫完成签到,获得积分20
3秒前
HEAUBOOK完成签到,获得积分10
5秒前
Rand关注了科研通微信公众号
7秒前
激情的煎饼完成签到,获得积分10
7秒前
nice1025完成签到,获得积分10
8秒前
不见高山完成签到,获得积分10
8秒前
小喜完成签到,获得积分20
9秒前
11秒前
科研通AI5应助jiajia采纳,获得10
13秒前
14秒前
14秒前
15秒前
谦让月饼完成签到 ,获得积分10
15秒前
Hello应助科研通管家采纳,获得10
15秒前
wanci应助科研通管家采纳,获得10
16秒前
研友_VZG7GZ应助科研通管家采纳,获得10
16秒前
xiaxiao应助科研通管家采纳,获得100
16秒前
科研通AI5应助科研通管家采纳,获得10
16秒前
16秒前
猪猪hero应助科研通管家采纳,获得10
16秒前
慕青应助科研通管家采纳,获得10
16秒前
在水一方应助科研通管家采纳,获得10
16秒前
科研助手6应助科研通管家采纳,获得10
16秒前
猪猪hero应助科研通管家采纳,获得10
16秒前
李健应助科研通管家采纳,获得20
16秒前
ding应助科研通管家采纳,获得10
17秒前
猪猪hero应助科研通管家采纳,获得10
17秒前
小蘑菇应助科研通管家采纳,获得10
17秒前
17秒前
小马甲应助科研通管家采纳,获得10
17秒前
大模型应助科研通管家采纳,获得10
17秒前
orixero应助科研通管家采纳,获得10
17秒前
研友_VZG7GZ应助科研通管家采纳,获得30
17秒前
17秒前
王婷静完成签到,获得积分10
18秒前
18秒前
renpp822发布了新的文献求助10
19秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Mindfulness and Character Strengths: A Practitioner's Guide to MBSP 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776768
求助须知:如何正确求助?哪些是违规求助? 3322170
关于积分的说明 10209047
捐赠科研通 3037424
什么是DOI,文献DOI怎么找? 1666679
邀请新用户注册赠送积分活动 797625
科研通“疑难数据库(出版商)”最低求助积分说明 757921